HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylvie Bodard Selected Research

Boron

12/2019Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [18F] PET tracer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylvie Bodard Research Topics

Disease

9Neuroinflammatory Diseases
06/2021 - 12/2008
8Parkinson Disease (Parkinson's Disease)
06/2021 - 07/2007
4Alzheimer Disease (Alzheimer's Disease)
06/2021 - 11/2007
2Gliosis
01/2014 - 02/2012
1Neoplasms (Cancer)
01/2022
1Inflammation (Inflammations)
01/2022
1Chorioamnionitis
11/2021
1Brain Diseases (Brain Disorder)
11/2021
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Huntington Disease (Huntington's Disease)
01/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1Leigh Disease (Leigh's Disease)
10/2016
1Dyskinesias (Dyskinesia)
07/2013
1Psychotic Disorders (Schizoaffective Disorder)
07/2013
1Constipation
07/2013
1Parkinsonian Disorders (Parkinsonism)
07/2013
1T-Cell Leukemia (Leukemia, T Cell)
12/2010
1Stroke (Strokes)
12/2010
1Autistic Disorder (Autism)
02/2010
1Brain Injuries (Brain Injury)
03/2006

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2015 - 11/2007
4Oxidopamine (6 Hydroxydopamine)IBA
06/2021 - 07/2012
4Quinolinic AcidIBA
01/2021 - 01/2013
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2021 - 01/2015
3N- (1- azabicyclo(2.2.2)oct- 3- yl)furo(2,3- c)pyridine- 5- carboxamideIBA
06/2021 - 01/2015
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2016 - 07/2007
2Neuroprotective AgentsIBA
06/2021 - 01/2018
2LigandsIBA
02/2012 - 12/2008
2Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA
12/2007 - 11/2007
1Pharmaceutical PreparationsIBA
01/2022
1Tryptophan (L-Tryptophan)FDA Link
01/2022
1MelatoninIBA
11/2021
1pyridineIBA
06/2021
1Sigma-1 ReceptorIBA
06/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1BoronIBA
12/2019
1EstersIBA
12/2019
1Neuropeptide YIBA
10/2019
1Heme Oxygenase-1IBA
01/2018
1ElementsIBA
01/2018
1CytokinesIBA
01/2016
1PK 11195 (PK11195)IBA
01/2015
18- ((E)- 4- fluoro- but- 2- enyl)- 3beta- p- tolyl- 8- aza- bicyclo(3.2.1)octane- 2beta- carboxylic acid methyl esterIBA
01/2015
1NicotineFDA Link
01/2015
1Levodopa (L Dopa)FDA LinkGeneric
07/2013
1IronIBA
01/2013
1Heme (Haem)IBA
01/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013
1Glycoproteins (Glycoprotein)IBA
12/2010
1Valproic Acid (Depakote)FDA LinkGeneric
02/2010
1Cholinergic Agents (Cholinergics)IBA
11/2007
1benzovesamicolIBA
11/2007
1Caspase 3 (Caspase-3)IBA
03/2006
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
03/2006

Therapy/Procedure

3Therapeutics
01/2022 - 06/2008
1Microbubbles
01/2022
1Drug Therapy (Chemotherapy)
01/2022
1Intraperitoneal Injections
01/2018
1Transplantation
06/2008